04 Jan 2019 --- Biotech company Amyris, Inc. has signed a long-term agreement with Xinfu of China, for a significant initial payment and a long-term minimum annual share of an existing nutritional product royalty arrangement. This agreement is aimed at enabling the company to monetize a portion of the long-term royalty opportunity to better manage volatility in a high-margin revenue stream, while maintaining access to future upside in the royalty payment structure.
